CLINICAL TRIALSOF NEW DRUGS.DOLLERY CT; WADE OL; TURNER P et al.1977; J. R. COLL. PHYSICIANS LONDON; G.B.; DA. 1977; VOL. 11; NO 3; PP. 226-233; BIBL. 1 REF.Article

Design Issues in Randomized Phase II/III TrialsKORN, Edward L; FREIDLIN, Boris; ABRAMS, Jeffrey S et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 667-671, issn 0732-183X, 5 p.Article

Les ellipticines et aza-ellipticines = Ellipticins and aza-ellipticinsGISSELBRECHT, C; MARTY, M; MIGNOT, L et al.Actualités hématologiques. 1984, Vol 18, pp 193-207, issn 0567-8757Article

Characterization and multiparameter analysis of visual adverse events in Irofulven single-agent Phase I and II trialsRAYMOND, Eric; KAHATT, Carmen; CULLEN, Michael et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7566-7574, issn 1078-0432, 9 p.Article

La loi Huriet-Serusclat : ce qui a changéDEYGAS, Béatrice.MT. Médecine thérapeutique. 2005, Vol 11, Num 1, pp 11-13, issn 1264-6520, 3 p.Article

Guidelines for clinical evaluation of antiepileptic drugsEpilepsia (Copenhagen). 1989, Vol 30, Num 4, pp 400-408, issn 0013-9580Article

Journées de pharmacogie cliniqueThérapie (Paris). 1992, Vol 47, Num 5, pp 455-465, issn 0040-5957Conference Proceedings

Klinische Erfahrungen mit dem kurzwirksamen Opioid Alfentanil (Rapifen^®) = Essais cliniques de l'opioide à action courte alfentanil (rapifen*) = Clinical experiences with the short acting opioid alfentanil (rapifen*)JOST, U; HIRSCHAUER, M; SCHMID, A et al.Anästhesie, Intensivtherapie, Notfallmedizin. 1984, Vol 19, Num 1, pp 8-13, issn 0174-1837Article

Anticorps monoclonaux à usage thérapeutique: spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long termePAINTAUD, Gilles; DIVINE, Marine; LECHAT, Philippe et al.Thérapie (Paris). 2012, Vol 67, Num 4, pp 319-327, issn 0040-5957, 9 p.Article

Time to mandate data release and independent audits for all clinical trialsHAINES, Ian E; GABOR MIKLOS, George L.Medical journal of Australia. 2011, Vol 195, Num 10, pp 575-577, issn 0025-729X, 3 p.Article

Randomized Phase II Trials: Inevitable or Inadvisable?GAN, Hui K; GROTHEY, Axel; POND, Gregory R et al.Journal of clinical oncology. 2010, Vol 28, Num 15, pp 2641-2647, issn 0732-183X, 7 p.Article

The benefits of participation in clinical trialsVAN DONGEN, J. A; VAN DE VELDE, C. J. H.European journal of surgical oncology. 1996, Vol 22, Num 6, pp 561-562, issn 0748-7983Article

Early clinical trials of mitoxantrone = Premiers essais cliniques de la mitoxantroneBODEY, G. P; VALDIVIESO, M; HWEE-YONG YAP et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 103-114, issn 0146-0447Article

MANAGEMENT OF TRIALS IN THE DEVELOPMENT OF CANCER CHEMOTHERAPY.WILLIAMS CJ; CARTER SK.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 434-447; BIBL. 24 REF.Article

THE CANCER THERAPY EVALUATION PROGRAM OF THE NATIONAL CANCER INSTITUTEMUGGIA FM; CARTER SK; MACDONALD JS et al.1981; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1981; VOL. 8; NO 4; PP. 394-402; BIBL. 49 REF.Article

Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differencesMOORE, R. A; DERRY, S; MCQUAY, H. J et al.Pain (Amsterdam). 2010, Vol 149, Num 2, pp 173-176, issn 0304-3959, 4 p.Article

Flexibility of single-subject experimental designs. I: Review of the basics of single-subject designsMCREYNODS, L. V; THOMSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 194-203, issn 0022-4677Article

Flexibility of single-subject experimental designs. II: Design selection and arrangement of experimental phasesKEARNS, K. P.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 204-214, issn 0022-4677Article

Calculation of power for matched pair studies when randomization is by groupSHIPLEY, M. J; SMITH, P. G; DRAMAUX, M et al.International journal of epidemiology. 1989, Vol 18, Num 2, pp 457-461, issn 0300-5771, 5 p.Article

Flexibility of single-subject experimental designs. III: Using flexibility to design or modify experimentsCONNELL, P. J; THOMPSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 214-225, issn 0022-4677Article

First clinical trials of the Twente Photoacoustic Mammoscope (PAM)VAARTJES, Susanne E; VAN HESPEN, Johan C. G; KLAASE, Joost M et al.Progress in biomedical optics and imaging. 2007, Vol 6629, pp 662917.1-662917.12, issn 1605-7422, isbn 978-0-8194-6773-7, 1VolConference Paper

Time trialsCOWAP, Simon.Medical journal of Australia. 2005, Vol 183, Num 2, issn 0025-729X, p. 72Article

Generalising the results of trials to clinical practiceSEALE, J. Paul; GEBSKI, Val J; KEECH, Anthony C et al.Medical journal of Australia. 2004, Vol 181, Num 10, pp 558-560, issn 0025-729X, 3 p.Article

Pharmacology and clinical experienceLASKIN, O. L.Archives of internal medicine (1960). 1984, Vol 144, Num 6, pp 1241-1246, issn 0003-9926Article

Quality of antibiotic clinical trialsNORRBY, R.Journal of antimicrobial chemotherapy (Print). 1984, Vol 14, Num 3, pp 205-208, issn 0305-7453Article